Jim Cramer stated he now likes having a position in Moderna for the first time in ages. His endorsement may sway investor sentiment and highlights recent positive developments in Moderna's mRNA pipeline. Jim Cramer,Moderna,retail investors Increased retail interest could exert upward pressure on Moderna's stock, prompting further analyst commentary. Jim Cramer, a prominent TV personality and former hedge fund manager, said he now likes having a position in Moderna for the first time in ages. This shift may reflect recent positive developments such as favorable FDA votes or pipeline updates. While no specific financial details were provided, the comment could influence retail investor sentiment toward the biotech stock.
INTELLIGENCE
Social Pulse
AI estimate · not scraped